Literature DB >> 8746707

Figures of merit (FOMs) for imaging and therapy using monoclonal antibodies.

L E Williams1, A Liu, A M Wu, T Odom-Maryon, A Chai, A A Raubitschek, J Y Wong.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 8746707     DOI： 10.1118/1.597646

Source DB:  PubMed          Journal:  Med Phys        ISSN： 0094-2405            Impact factor:   4.071


× No keyword cloud information.
  8 in total

Review 1.  Anniversary paper: nuclear medicine: fifty years and still counting.

Authors:  Lawrence E Williams
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

Review 2.  Immuno-positron emission tomography in cancer models.

Authors:  Smitha Reddy; Matthew K Robinson
Journal:  Semin Nucl Med       Date:  2010-05       Impact factor: 4.446

3.  A mechanistic compartmental model for total antibody uptake in tumors.

Authors:  Greg M Thurber; K Dane Wittrup
Journal:  J Theor Biol       Date:  2012-09-06       Impact factor: 2.691

4.  ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging.

Authors:  Tove Olafsen; Shannon J Sirk; Sebastian Olma; Clifton K-F Shen; Anna M Wu
Journal:  Tumour Biol       Date:  2012-03-06

5.  Monodispersed DOTA-PEG-conjugated anti-TAG-72 diabody has low kidney uptake and high tumor-to-blood ratios resulting in improved 64Cu PET.

Authors:  Lin Li; Fabio Turatti; Desiree Crow; James R Bading; Anne-Line Anderson; Erasmus Poku; Paul J Yazaki; Lawrence E Williams; Debra Tamvakis; Paul Sanders; David Leong; Andrew Raubitschek; Peter J Hudson; David Colcher; John E Shively
Journal:  J Nucl Med       Date:  2010-06-16       Impact factor: 10.057

6.  124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.

Authors:  Gobalakrishnan Sundaresan; Paul J Yazaki; John E Shively; Ronald D Finn; Steven M Larson; Andrew A Raubitschek; Lawrence E Williams; Arion F Chatziioannou; Sanjiv S Gambhir; Anna M Wu
Journal:  J Nucl Med       Date:  2003-12       Impact factor: 10.057

Review 7.  Review: update on selection of optimal radiopharmaceuticals for clinical trials.

Authors:  Lawrence E Williams; George Lopatin; Daniel D Kaplan; An Liu; Jeffrey Y C Wong
Journal:  Cancer Biother Radiopharm       Date:  2008-12       Impact factor: 3.099

Review 8.  Multimodality imaging of the HER-kinase axis in cancer.

Authors:  Weibo Cai; Gang Niu; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-11       Impact factor: 9.236
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.